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Abstract
Background: Polychlorinated biphenyls (PCBs) are ubiquitous environmental toxins. Although there is growing
evidence to support an association between PCBs and deficits of neurodevelopment, the specific mechanisms are
not well understood. The potentially different roles of specific PCB groups defined by chemical structures or
hormonal activities e.g., dioxin-like, non-dioxin like, or anti-estrogenic PCBs, remain unclear. Our objective was to
examine the association between prenatal exposure to defined subsets of PCBs and neurodevelopment in a cohort
of infants in eastern Slovakia enrolled at birth in 2002-2004.
Methods: Maternal and cord serum samples were collected at delivery, and analyzed for PCBs using high-
resolution gas chromatography. The Bayley Scales of Infant Development -II (BSID) were administered at 16 months
of age to over 750 children who also had prenatal PCB measurements.
Results: Based on final multivariate-adjusted linear regression model, maternal mono-ortho-substituted PCBs were
significantly associated with lower scores on both the psychomotor (PDI) and mental development indices (MDI).
Also a significant association between cord mono-ortho-substituted PCBs and reduced PDI was observed, but the
association with MDI was marginal (p = 0.05). Anti-estrogenic and di-ortho-substituted PCBs did not show any
statistically significant association with cognitive scores, but a suggestive association between di-ortho-substituted
PCBs measured in cord serum and poorer PDI was observed.
Conclusion: Children with higher prenatal mono-ortho-substituted PCB exposures performed more poorly on the
Bayley Scales. Evidence from this and other studies suggests that prenatal dioxin-like PCB exposure, including
mono-ortho congeners, may interfere with brain development in utero. Non-dioxin-like di-ortho-substituted PCBs
require further investigation.
Background
Polychlorinated biphenyls (PCBs) are ubiquitous envir-
onmental toxins. Improper disposal has been a major
source of environmental contamination. Their produc-
tion and use were banned in most industrialized coun-
tries in the late 1970s because of toxic effects in wildlife
[1,2].
PCBs have been shown to have toxic effects on var-
ious organs including tissues of the nervous, reproduc-
tive, and immunologic systems [3-7]. Although there is
growing evidence from in vivo and in vitro studies to
support the hypothesis of adverse effects of PCBs on
neurodevelopment [6-9], the mechanisms are not well
understood. Additionally, various epidemiological studies
have found an association between PCB exposure and
decreased cognitive development [10-15].
The most well-known mechanism related to adverse
health effects such as immune suppression, hepatotoxi-
city, and thymic atrophy is aryl hydrocarbon (Ah) recep-
tor-mediated pathways for dioxin- like PCBs [16,17].
Since non-dioxin-like PCBs have shown low affinity for
the Ah receptor [18], they have been regarded as poten-
tially less toxic. However, neurotoxicity [19], carcino-
genicity [20,21], and changes in hormones [22] have also
been described as resulting from non-dioxin-like PCBs.
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PCBs has been studied, and estrogen-like activity of
PCBs was reported to change brain dopamine (DA) con-
centration [23,24] or aromatase activity [25]. Gonadal
hormones such as estrogens can alter the structure and
function of the hippocampus, which is critical for spatial
and declarative learning and memory, and they modu-
late neural circuits by interacting with various neuro-
transmitters [26]. Besides playing a major role in sex
differences, including sexual dimorphic behaviors, they
modulate hypoxia-induced injury of neurons in the hip-
pocampus [27] and influence synaptic patterning [28].
Estradiol protects against free radicals and regulates
apoptosis [29], and these effects might depend on brain
regions and timing of exposure. When bound to estro-
gen receptors, the complex regulates transcription[30].
PCBs have been proposed to affect brain development
through an estrogen-receptor mediated pathway [31].
Specific steroidal pathways that might mediate PCB
effects on cognitive and motor development have yet to
be determined.
Previously, several epidemiological studies have evalu-
ated the effects of PCBs on neurodevelopment. If only
the Bayley Scales of Infant Development (BSID) assess-
ment is considered, findings across studies are inconsis-
tent. A Michigan study in a fishing community [32] and
a study from 12 sites across the United States [33]
found no association between BSID scores at 8 months
and prenatal PCB exposure. In contrast, studies from
North Carolina [34,35] and the Netherlands [14]
observed prenatal PCB exposure to be associated with
lower psychomotor development index (PDI) scores at
3, 6, 12, and 24 months whereas a study in Germany
[15] found PCBs in breast milk, used as a surrogate
measure for prenatal exposure, to be associated with
decreased mental development index (MDI), but not
with psychomotor development index (PDI), at 7
months of age. Several previous studies that used other
instruments than the Bayley scales at different ages
reported that PCBs were associated with detrimental
effects on children’s neurodevelopment [10,12,13,36,37].
Because of the lengthy half-lives of PCBs, any mea-
surement in serum represents an accumulation of expo-
sure over a period of years. These compounds circulate
in the serum lipids and cross the placenta, albeit less
efficiently than their hydroxy-metabolites [38]; nonethe-
less, the consistency of cord:maternal ratios across
exposure levels provides the rationale for use of mater-
nal concentrations as a surrogate for fetal exposures.
The present study investigated associations between
prenatal PCB exposures, measured from maternal and
cord sera, characterized by their chemical structures
and hormonal activities, and neurodevelopment
measured by BSID among 16-month-old infants in
eastern Slovakia.
Methods
Study population
Mother/infant pairs for a birth cohort were recruited at
delivery between 2002 and 2004 from two districts in
eastern Slovakia–Michalovce with high PCB contamina-
tion from a chemical manufacturing plant, and Svidnik
located around 70 kilometers to the northwest, with
lower levels of PCBs. Each district has only one hospital,
and the vast majority of births from these regions occur
in these hospitals. For eligibility criteria, we excluded
women with more than four previous births, who were
less than 18 years old at the time of their child’sb i r t h ,
or who had resided fewer than five years in their dis-
trict. Mothers with a major health condition such as
cancer or mental illness and infants who had severe
birth defects were also excluded.
Of the 1134 eligible participants, maternal PCB mea-
surements were determined in 1076 (blood samples
were not collected for the remaining 58), and because of
limited funding, cord PCBs were measured in 469. The
cord measurements were conducted on all samples as
they came into the laboratory until funding ran out, and
they are a sub-set of maternal serum samples. Of those
with maternal PCBs, data from 316 subjects were
excluded owing to missing BSID scores mostly resulting
from loss-to-follow-up (n = 311), or to missing lipid
measurements (n = 5), leaving n = 760. From the 469
cord PCB measures, infants without BSID scores (n =
156) or lipid values (n = 55) were excluded, leaving n =
258. Therefore, for the current statistical analysis of
neurodevelopment, we included those with BSID scores
and maternal serum PCB measurements (n = 760) or
with BSID scores and cord serum PCB measurements (n
= 258). This study was approved by Institutional Review
B o a r d so ft h eU n i v e r s i t yo fC a l i f o r n i aa tD a v i s ,U S A
(UC Davis) and the Slovak Medical University (SMU) in
Bratislava, Slovakia. Written informed consent was
obtained from all participants, and consent was given by
the parents for infants to participate in the study.
Specimen collection
All tubes of maternal and cord sera were refrigerated at
5 -10°C immediately after collection of blood at delivery.
Serum was isolated by centrifugation (15 min at 3000
RPM) in each local hospital and placed into a freezer
(-18°C). These specimens were then transported to the
SMU in thermo boxes with cooling cartridges to pre-
vent thawing, and after aliquoting 0.2 ml for lipid mea-
surement, stored at -18°C until PCB analysis was
performed.
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The concentrations of 15 PCB congeners (PCB IUPAC
#28, #52, #101, #105, #114, #118, #123, #138, #153,
#156, #157, #167, #170, #180, and #189) were deter-
mined in the maternal and cord serum samples by high-
resolution gas chromatography with electron capture
detection [39,40]. This choice was based on the capabil-
ity of gas chromatographic (GC) electron capture detec-
tion (ECD) to provide sufficient response for the so-
called indicator PCB and dioxin-like PCB congeners. for
example, the non-ortho substituted dioxin-like PCBs
(#77, 81, 126, and 169) were not determinable by means
of ECD when 4 mL or less of serum is available, as
results would all be below the limits of detection (LOD).
Additionally, PCB levels in babies are lower than those
in adults and, moreover, the collected volume of serum
was often low. As a consequence, only a handful of PCB
congeners (#118, 138, 153, 156, 170, and 180) out of the
15 had most values above their LODs. Fitting models to
poorly characterized exposure distributions is likely to
be misleading, as would be the case if most sample
results are < LOD. We focused our statistical analyses
on the 6 congeners for which a high proportion of the
samples was > LOD.
For analysis of PCBs, PCB #174 as an extraction stan-
dard was added to the blood serum before the analytes
were isolated using solid phase extraction. The solid-
phase extraction (SPE) extract was concentrated and
then cleaned by passing through a Florisil-H2SO4/silica
gel column. The eluate was then evaporated to a small
volume, and PCB #103 was added as a syringe standard
to correct the final volume of samples before GC injec-
tion. An aliquot of the mixture was injected and ana-
lyzed on a chromatography system (HP 5890, Hewlett-
Packard, Palo Alto, CA) equipped with a Ni-63 electron
capture detector using a 60m DBP-5 capillary column
(J&W Scientific, Folsom, MA). Quantification was based
on the calibration curve generated by authentic PCB
standard solutions at five different concentration levels.
Quality control activities consisted of analyses of sam-
ples in batches of 10 simultaneously with a blank sample
and in-house reference material (spiked porcine serum).
Response for a particular congener had to be in the
range of 90-110% using the concentration of the middle
point of the calibration curves for that congener. The
limit of detection for each analyte was determined as
the mean of background noise plus three standard
deviations from five reagent blank samples. The detailed
methods for analysis have been described previously
[39,40].
The Department of Toxic Organic Pollutants at the
SMU performed the laboratory analyses. This accredited
laboratory has annually participated successfully in an
inter-laboratory comparison program organized by the
German External Quality Assessment Scheme
(G-EQUAS) for Analysis in Biological Materials at the
Friedrich-Alexander-University, Erlagen-Nuremberg as
well as the WHO-Coordinated Interlaboratory Quality
Assessment of Levels of PCBs, PCDDs and PCDFs in
Human Milk and Blood Plasma [35].
Lipids measurement
Total serum lipids (TL) were estimated using enzymatic
summation method [41]. Serum total cholesterol (TC)
and triglyceride (TG) were measured using a DuPont
aca III analyzer and cholesterol oxidase without choles-
terol esterase was used to detect free cholesterol (FC).
The method by Takayama et al.[42] was used to deter-
mine serum choline-containing phospholipids (PL).
Total serum lipids were calculated from the formula
TL = 1.677*(TC-FC) +FC+TG+PL. The lipids were mea-
sured at a biochemical laboratory accredited by the Slo-
vak National Accreditation Service located at the
Ministry of Defense Military hospital in Bratislava.
Neurodevelopmental assessment
The BSID-II [43] are age standardized scales for 1- 42
months used widely in screening in clinical practice and
for research studies of factors influencing development.
Choosing a specific neurodevelopment assessment tool
is complicated, in particular, for non-English speaking
countries. At 16 months of age, this was the best general
tool available with measures of both cognitive and
motor skills, two key indicators of development in the
second year of life, and the fact that the previous version
(I) of BSID had been standardized and used in Slovakia
was also an argument in its favor. Because BSID (II) had
been used in previous studies of PCBs, this choice
ensured comparability. The BSID (II) was administered
by one local psychologist in each district at the study’s
16-month follow-up visit. The two psychologists were
trained by one of the investigators (ES) and a scientific
advisory board member, both of whom are experienced
psychologists.
We used the two scales of the BSID, the mental devel-
opment index (MDI) and psychomotor development
index (PDI) for the constructs of cognitive and motor
development, respectively. The standardized MDI and
PDI scores of BSID were calculated from raw scores
based on child’s actual age and are reported as the out-
comes of interest. We videotaped 34 children in each
district using a fixed camera and the tapes were
reviewed by the psychologist in the other district to
evaluate inter-rater reliability.
Covariate measures
Major data sources for covariates for this analysis were
an interview with the mother conducted by trained staff
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newborn medical record. In addition to the collection of
socio-demographic and lifestyle factors, the Raven’s Pro-
gressive Matrices [44], a non-verbal intelligence test,
was administered to mothers after delivery. Additionally,
the Home Observation for Measurement of the Environ-
ment (HOME) [45], which assesses the quality and
quantity of stimulation given to a children in the home
environment, was administered at the clinics during the
16-month follow-up visit. Because the HOME was admi-
nistered at the clinics instead of the homes, we deleted
3 questions from the original version that were based on
direct observations about play materials in the home. In
a birth cohort study from Dusseldorf, scores from the
modified version were highly correlated with scores
from the full scale (Gerhard Winneke and Jens Walko-
wiak, Heinrich-Heine-University Dusseldorf, personal
communication, 2003).
Categorization of exposure variables
PCBs were categorized into different groups by their che-
mical structures (e.g., dioxin-like mono-ortho PCBs or
non-dioxin-like di-ortho PCBs) or their estrogenic or anti-
estrogenic properties based on the published literature
[22,46-54]. In our analyses, we included six of the most
abundant PCB congeners (PCB IUPAC #118, #138, #153,
#156, #170, and #180). For the values below limits of
detection (LOD), we imputed by taking the LOD value
divided by the square root of 2 for congeners that had
fewer than 20% of samples below the LOD [55,56] and the
LOD divided by 2 if >20% of samples fell below the LOD
(e.g., cord concentrations of PCB #118, and #156, which
had 41.5%, and 40.0%, respectively, below the LOD)
The two mono-ortho dioxin-like PCBs we measured
were #118 and #156 [17]. For non-dioxin-like di-ortho
PCBs, PCB #138, #153, #170, and #180 were included
[21]. PCB #138, #156, #170, and #180 were categorized
as anti-estrogenic. However, estrogenic PCB levels (#28,
#52, and #101) were low, with values for several conge-
ners mostly below the LOD (range: 60-85%) and hence
were not assessed for associations with neurodevelop-
mental scores in this study. These congener measure-
ments would be expected to largely represent noise.
Moreover, another investigation failed to find estrogenic
activity of these congeners [57]. Because of the reports
of mixed activity [22,46-50], PCB #105, #118, and #153
were excluded as anti-estrogenic PCBs for the analysis.
Data analysis
PCB concentrations were obtained on a wet weight basis
(ng/ml), and then adjusted for serum lipids (ng/mg total
lipid). As distributions of chemical concentrations were
skewed (Shapiro-Wilk test: p < 0.0001), lipid adjusted
PCB values were natural log- transformed.
As a first step in the data analysis, we examined the
crude association between PCBs and neurodevelopment.
To screen for confounders, we did bivariate analyses
regressing MDI scores, PDI scores, or PCBs on each
covariate (e.g., maternal age, education, smoking
and alcohol consumption, parity, ethnicity, gestational
age, birth weight, child’s sex, and maternal illness his-
tory), and examined these variables in a directed acyclic
graph [58].
Then multiple linear regression models were devel-
oped with a broad inclusion of all covariates showing an
association with the PDI or MDI of p <0 . 3 .W eu s e da
backward elimination approach and a change-in-esti-
mate of 10% as the criterion [59] for deciding which fac-
tors to include. District of residence was a design
variable and hence included in all models. Also, we
eliminated redundant variables, e.g., because maternal
education was highly correlated with maternal Raven’s
score and the HOME score, it was not included in the
final models. Separate regression models were built for
maternal and cord PCB concentrations. For interpreta-
tion of the regression model results, we took each beta
coefficient, and back-calculated to obtain the predicted
difference in BSID scores comparing the 25
th and 75
th
percentile values, using the regression model: E(Y) = a
*loge X, where X is PCB concentration, E(Y) is the
expectation of the Bayley score, and a is the beta
coefficient.
The SAS statistical package was used for analysis
(Version 9.1, SAS Institute, Cary, NC).
Results
Table 1 describes characteristics of two sub-popula-
tions with complete BSID scores and chemical mea-
surements from maternal (n = 760) or cord (n = 258)
serum samples, overall as well as by district. Charac-
teristics were very similar between these two subsets,
including maternal age, education and smoking his-
tory. However, in the group with cord PCB levels
measured, there were slightly more female babies and
more mothers who consumed alcohol during either
the pregnancy or the three months before conception,
in comparison with the larger group having maternal
PCB measurements. By district, Svidnik had more
maternal alcohol consumption history than Micha-
lovce. Concentrations of the maternal and cord PCBs
overall, as well as by district, are shown in Table 2.
After lipid adjustment, the concentrations from the
cord sera were slightly lower than those from the
maternal sera (p < 0.0001), however the differences
were greater for mono-ortho-substituted PCB conge-
ners, for which the overall median of cord levels was
about half the median concentration in the mothers.
Overall, Svidnik had lower levels of PCB exposure
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Page 4 of 13Table 1 Characteristics of the study groups in two districts of eastern Slovakia, 2002-2004
Characteristics Mother (N = 760) Cord (N = 258)
% (n) % (n)
Total Michalovce Svidnik Total Michalovce Svidnik
(n = 760) 73.5(559) 26.5(201) (n = 258) 70.2(181) 29.8(77)
Maternal age
< 19 2.6 (20) 2.6 (15) 2.5 (5) 2.3 (6) 2.8(5) 1.3(1)
< 29 70.0(532) 71.6 (400) 65.7(132) 70.2 (181) 71.8(130) 66.2(51)
29 + 27.4(208) 25.8 (144) 31.8 (64) 27.5 (71) 25.4 (46) 32.5(25)
Maternal education
Basic schooling 18.4 (140) 21.3(119) 10.5(21) 18.2 (47) 21.5 (39) 10.4 (8)
High school without graduation 27.4 (208) 27.4(153) 27.4(55) 26.0 (67) 26.5 (48) 26.7 (19)
High school with graduation 46.7 (355) 45.3(253) 50.8(102) 48.8(126) 45.9 (83) 55.8 (43)
More than College/University 7.0 (53) 5.5(31) 10.9(22) 6.6 (17) 5.5 (10) 9.1 (7)
Missing 0.5 (4) 0.5(3) 0.5(1) 0.4 (1) 0.6(1) -
Sex of child
Male 51.3 (390) 51.3 (287) 51.2(103) 47.3(122) 49.7 (90) 41.6 (32)
Female 48.7 (370) 48.7(272) 48.8(98) 52.7(136) 50.3 (91) 58.4 (45)
Ethnicity
Slovakian/other eastern European 79.2 (602) 77.3(432) 84.6(170) 79.8 (206) 77.6(140) 85.7 (66)
Romani 18.6 (141) 19.7(110) 15.4(31) 17.1 (44) 18.2 (33) 14.3 (11)
Missing 2.2 (17) 3.0(17) - 3.1 (8) 4.4 (8) -
Marital status
Married or living with partner 91.6 (696) 90.0(503) 96.0(193) 91.4 (236) 89.5 (162) 96.1 (74)
Never married 5.5 (42) 6.1(34) 4.0(8) 4.7 (12) 5.5 (10) 2.6 (2)
Divorced/widowed 2.4 (18) 3.2(18) - 2.7 (7) 3.3 (6) 1.3 (1)
Missing 0.5 (4) 0.7(4) - 1.2 (3) 1.7(3) -
Maternal smoking
No 62.8 (477) 61.4 (343) 66.7(134) 61.2 (158) 56.9 (103) 71.4 (55)
Yes 34.8 (265) 35.6 (199) 32.8 (66) 35.7 (92) 38.7(70) 28.6 (22)
Missing 2.4 (18) 3.0 (17) 0.5 (1) 3.1 (8) 4.4 (8) -
Maternal Alcohol consumption
No 69.0 (525) 77.6 (434) 45.3 (91) 59.3 (153) 65.8 (119) 44.2 (34)
Yes 28.6 (217) 19.3 (108) 54.2(109) 37.6 (97) 29.8 (54) 55.8(43)
Missing 2.4 (18) 3.1(17) 0.5(1) 3.1 (8) 4.4 (8) -
Parity
0 38.4 (292) 39.0(218) 36.8(74) 38.4 (99) 40.9(74) 32.5 (25)
1 34.7 (264) 35.2(197) 33.3(67) 31.4 (81) 29.8 (54) 35.1(27)
2 17.9 (136) 17.5(98) 18.9(38) 20.5 (53) 21.0 (38) 19.5 (15)
3 8.6 (65) 7.7(43) 11.0(22) 8.5 (22) 6.6 (12) 13.0 (10)
4 0.3 (2) 0.4(2) - 0.8 (2) 1.1(2) -
Missing 0.1 (1) 0.2(2) - 0.4 (1) 0.6 (1) -
Maternal hyper- or hypothyroidism history
No 94.7 (720) 94.5(528) 95.5(192) 93.4 (241) 93.9 (170) 92.2 (71)
Yes 3.1 (23) 2.5(14) 4.5 (9) 3.5 (9) 1.7 (3) 7.8(6)
Missing 2.2 (17) 3.0 (17) - 3.1 (8) 4.4(8) -
Maternal diabetes history
No 96.6 (734) 95.7 (535) 99.0(199) 95.3 (246) 94.5(171) 97.4 (75)
Yes 1.2 (9) 1.3 (7) 1.0 (2) 1.6 (4) 1.1(2) 2.6 (2)
Missing 2.2 (17) 3.0(17) - 3.1 (8) 4.4(8) -
Raven’s score
Mean (SD) 41.0(12.9) 40.6 (13.7) 42.2 (10.4) 40.5 (13.3) 39.4 (14.1) 43.8 (11.1)
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lapped considerably.
Table 3 presents the summary of estimated coeffi-
cients, their standard errors, and p-values for exposure
variables in multiple linear regression models predicting
Bayley scales (MDI and PDI) after adjusting for residen-
tial district, HOME scores, sex, and Raven scores of
mothers. Neither maternal nor cord di-ortho-substituted
PCBs (#138, #153, #170, and #180) were associated with
the Bayley scores, and there was no association between
the group of anti-estrogenic PCBs (#138, #156, #170,
and #180) and the Bayley scores. In contrast, concentra-
tions of dioxin-like mono-ortho PCBs (sum of #118 and
#156) were associated with significantly lower scores on
both the MDI and PDI Scales, using either maternal or
cord PCB measurements. Findings for the mono-ortho-
substituted PCBs were similar for maternal and cord
PCBs (Intraclass correlation (ICC):0.88), particularly in
relation to the PDI. For the non-dioxin-like, di-ortho-
substituted PCB congeners (ICC: 0.95), an association
was present for the PDI only and was stronger with
cord than with maternal PCB concentrations.
Additionally, each of the 6 major PCB congeners
(#118, #138, #153, #156, #170, and #180) was tested in
separate regression models, and maternal and cord con-
centrations of PCB #118 were most strongly associated
with reduced BSID.
Table 4 shows separate final full multiple regression
models with confounders, namely, district, HOME
score, Raven’s score, and sex of the babies, predicting
MDI and PDI from the mono-ortho-substituted PCBs
in maternal and cord sera. The interpretation of these
coefficients is that when the maternal concentration of
the sum of the two mono-ortho dioxin-like PCBs is
increased from the 25
th to 75
th percentile in this study
(0.012 to 0.036 ng/mg lipids), MDI (p < 0.001) and
PDI (p = 0.02) are reduced by approximately -1.8 and
-1.4 points, respectively. Similarly, the inter-quartile
increase of the sum of these same PCBs in cord serum
(0.005 to 0.028 ng/mg lipids) was significantly asso-
ciated with -3.4 point reduction in PDI (p =0 . 0 2 ) ,b u t
marginally with -2.4 points in MDI (p =0 . 0 5 ) .R e g a r d -
ing other covariates, girls had a higher MDI and PDI
in comparison with boys. As expected, higher HOME
and maternal Raven scores were associated with higher
MDI and PDI.
Discussion
We observed higher concentrations of two mono-ortho
PCBs in maternal sera to be associated with decrements
in neurodevelopment at 16 months of age. Several lab-
based studies reported alteration of dopamine (DA)
levels, changes of behavior, or a reduction in long-term
potentiation (LTP), regarded as the cellular and molecu-
lar mechanisms that are linked to some forms of learn-
ing and memory, by coplanar dioxin-like PCBs such as
congener #77 or #126 [60-64]. However, other studies in
rats reported that the coplanar dioxin-like PCB #126
was not associated with deficits in attention and beha-
vioral performances [65,66].
Regarding epidemiological studies, although the birth
cohort study from the Netherlands found an association
of coplanar and mono-ortho dioxin-like PCBs (# 77,
126, 169, 105, 118, 156) in breast-milk collected two
weeks after delivery with suboptimality at birth, their
findings were null at 7, and 18 months for the PDI and
MDI except they found a significant association with
decreased PDI at 3 months [14,67,68].
Reports from Germany indicated reduced MDI at 7,
18 and 30 months in relation to prenatal PCBs (the sum
of PCB #138, #153, and #180), although the 18-month
scores were somewhat less precise (p =0 . 0 6 )a sc o m -
pared with the other time points [13,15]. Our study
didn’t show associations with either non-dioxin like
PCBs or the sum of PCB #138, #153, and #180 even
though the concentration of the sum of PCB #138,
#153, and #180 was higher than that of German study
(1.16 vs 0.55 ng/ml) [15]. It is not certain if our incon-
sistent findings with the German study were from differ-
ences between the two studies in other nonquantitated
PCBs or in other chemical compounds that correlated
with the measured non-dioxin like PCBs, or for other
methodologic reasons.
A study with 6-month-old children in Japan [69]
reported no statistically significant association between
prenatal non-dioxin like PCBs (#170, #180) and the Bay-
ley scores while some dioxin-like PCBs (#118,#126,
#157, and #189) showed suggestive associations with
reduced PDI (p <0 . 1 )b u tn o tM D I .C o m p a r e dt oo u r
levels of maternal PCBs, median concentrations in this
study of PCB #118, #156, #170, and #180 were lower by
a range of approximately 2 to 13 fold. Some research on
non-dioxin-like PCBs [24,70] suggests that they tend to
Table 1 Characteristics of the study groups in two districts of eastern Slovakia, 2002-2004 (Continued)
MDI
Mean (SD) 93.8 (13.4) 93.1(13.5) 95.7 (13.0) 91.0(13.5) 89.7 (13.7) 94.1 (12.7)
PDI
Mean (SD) 99.8 (15.1) 103.1(14.3) 90.6(13.6) 98.6 15.4) 100.9 (15.5) 93.0 (13.7)
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PCBs through various mechanisms: interference with
protein kinase C(PKC) [70,71], changes in DA levels
[23], and apoptosis [72]. In contrast to some other epi-
demiological or lab-based studies [13,15,24,70], we
found the evidence was weaker for a relationship
between neurodevelopment and prenatal exposures to
di-ortho-substituted PCBs, although a suggestive
association was observed with PDI (b =- . 1 9 5 ,p =0 . 0 9 )
from these compounds measured in cord, but not in
maternal samples (Table 3).
Both mono-ortho and di-ortho substituted PCBs can
affect nervous system tissues, but these effects are possi-
bly mediated by different pathways [73]. In a related
publication, we evaluated the hydroxylated metabolites
of PCBs in relation to the scores on the Bayley Scales
Table 2 Distributions of maternal and cord PCBs concentration (ng/mg lipids) in two districts of eastern Slovakia,
2002-2004
5
th 25th 50th 75th 95th Mean SD
Maternal sera
∑ 4 Major PCBs
† (non-dioxin-like PCBs) Total (n = 760) 0.159 0.280 0.414 0.659 1.583 0.590 0.663
Michalovce (n = 559) 0.197 0.346 0.502 0.751 1.815 0.685 0.718
Svidnik (n = 201) 0.122 0.193 0.254 0.356 0.660 0.324 0.366
∑ Dioxin-like mono-ortho PCBs
† Total 0.005 0.012 0.021 0.036 0.093 0.032 0.047
Michalovce 0.005 0.015 0.025 0.041 0.106 0.037 0.052
Svidnik 0.003 0.008 0.014 0.019 0.038 0.017 0.018
∑Anti-estrogenic PCBs
† Total 0.108 0.194 0.284 0.458 1.093 0.410 0.470
Michalovce 0.136 0.237 0.347 0.523 1.255 0.478 0.511
Svidnik 0.085 0.131 0.174 0.248 0.424 0.222 0.249
Cord sera
∑ 4 Major PCBs (non-dioxin-like PCBs) Total (n = 258) 0.096 0.228 0.380 0.666 1.477 0.548 0.537
Michalovce (n = 181) 0.177 0.332 0.493 0.807 1.584 0.682 0.584
Svidnik (n = 77) 0.067 0.139 0.216 0.280 0.555 0.231 0.142
∑ Dioxin-like -substituted PCBs Total 0.003 0.005 0.011 0.028 0.084 0.022 0.030
Michalovce 0.004 0.007 0.017 0.034 0.089 0.028 0.034
Svidnik 0.003 0.004 0.005 0.008 0.031 0.008 0.008
∑Anti-estrogenic PCBs Total 0.062 0.154 0.246 0.441 0.985 0.372 0.384
Michalovce 0.120 0.225 0.343 0.547 1.053 0.465 0.421
Svidnik 0.043 0.085 0.145 0.188 0.375 0.152 0.097
† ∑ 4 major PCBs (non-dioxin-like PCBs), sum of PCB #138, #153, #170 and #180; ∑ Dioxin-like PCBs, sum of PCB #118, and #156; ∑ Anti-estrogenic PCBs, sum of
PCB #138, #156, #170, and #180
Table 3 Estimated coefficients with p-values of PCBs and their subsets in relation to BISD at age of16 months, 2002-
2004
†
Log transformed Maternal sera (N = 760) Cord sera (N = 258)
Exposure Variables MDI PDI MDI PDI
b SE b SE b SE b SE
4 major PCBs
‡ (∑non-dioxin-like PCBs) -0.39 0.62 -0.59 0.73 -1.02 0.94 -1.95* 1.13
∑ Dioxin-like mono-ortho PCBs
‡ -1.60*** 0.45 -1.26** 0.53 -1.40* 0.72 -1.99** 0.87
∑Anti-estrogenic PCBs
‡ -0.47 0.61 -0.58 0.72 -0.93 0.94 -1.85 1.13
PCB 118 -1.17*** 0.39 -1.04** 0.46 -1.44** 0.64 -2.04*** 0.77
PCB 138 -0.30 0.59 -0.53 0.70 -1.35 0.91 -2.27** 1.09
PCB 153 -0.33 0.62 -0.63 0.73 -1.22 0.94 -2.14* 1.14
PCB 156 -1.46*** 0.43 -1.02** 0.50 -0.50 0.71 -0.63 0.86
PCB 170 -0.54 0.60 -0.58 0.71 -0.62 0.77 -1.90* 0.94
PCB 180 -0.36 0.61 -0.47 0.72 -0.55 0.94 -1.26 1.13
*P < 0.1; **P < 0.05; *** P < 0.01; Regression parameter coefficients represent score change in PDI and MDI for a one-unit change in loge [exposure concentration
ng/mg lipid].
‡ ∑4 major PCBs (non-dioxin-like PCBs), sum of PCB #138, #153, #170 and #180; ∑ Dioxin-like mono-ortho PCBs, sum of PCB #118, and #156; ∑Anti-estrogenic
PCBs, sum of PCB #138, #156, #170, and #180
† After adjusting for district, HOME, sex, Raven score from multiple linear regression models.
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Page 7 of 13and reported that 4-OH-PCB107 was the only metabo-
lite that showed any relationship to neurodevelopment
at 16 months [74]. Both maternal and cord serum con-
centrations of 4-OH-PCB107 were associated with defi-
cits on the MDI, and cord levels were also associated
with deficits on the PDI. As 4-OH-PCB107 is the meta-
bolite of the two congeners PCB #105 and PCB #118,
both being mono-ortho substituted, the two investiga-
tions present a consistent signal: increased prenatal
exposures to both the parent mono-ortho PCB com-
pounds and the hydroxylated metabolites of those
mono-ortho PCBs occur in association with lower neu-
robehavioral scores. The question therefore arises:
through what mechanism might one or more of these
compounds, but not the di-ortho substituted congeners
and corresponding metabolites measured in our cohort,
act?
Mechanisms hypothesized to underlie PCB neurotoxi-
city have included thyroid disruption [75], interference
w i t hs e xs t e r o i d se i t h e ra sa g o n i s t so ra n t a g o n i s t s
[64,76], and Ah-receptor activity. Thyroid hormones are
critical to neuronal proliferation, migration, synaptogen-
esis, and brain myelination [77]. It has long been
hypothesized that one mechanism for neurodevelop-
mental toxicity of PCBs is through disruption of thyroid
hormones [78], and more recently, hydroxylated meta-
bolites have been implicated in this mechanism because
of greater transplacental transfer than the parent com-
pounds [79], high affinity for transthyretin, a transport
protein, and accumulation in fetal tissues, particularly 4-
OH-CB107 [80-82]. A recent in vitro study showed that
PCB 105 and/or 118 act as thyroid hormone receptor
agonists, but only in the presence of PCB 126 induction
of CYP1A1 [83]. The lack of a similar effect on thyroid
receptors from PCB #138 and #153 conforms with our
results, supporting plausibility of this mechanism for 4-
OH-CB107, the common metabolite of two mono-ortho
PCB #105 and #118, in impairment of neurodevelop-
ment. Disruption of thyroid hormones may itself operate
via altered cell signaling and/or neurotransmitters [78].
We did not find significant associations of neurodeve-
lopmental scores with anti-estrogenic PCBs (sum of
#138, 156, 170 and 180), but did not evaluate possible
roles of PCB metabolites with regard to estrogenic and/
or anti-estrogenic activities in this paper. As mentioned
above, in our previous work examining six hydroxylated
metabolites [74], only 4-OH-CB-107 was significantly
associated with decreased Bayley scores. Interestingly, an
in vitro study that examined inhibition of an estrogen
inactivator by OH-PCBs and subsequent increases in
estrogen levels at the target tissue, reported 4-OH-CB-
107 to be one of strongest inhibitors of the human
estrogen sulfotransferase (hEST), an enzyme that cata-
lyzes the sulfation and inactivation of estrogens. The
hEST activity was 1.5 to 2 orders of magnitude greater
than that observed for 4-OH-CB-146 or 4’-OH-CB-172
[84], metabolites of PCB 138, 153, and PCB 170, 180
respectively. Thus, despite previous mixed reports of
anti-estrogenicity [85] or estrogenicity [86] for 4-OH-
CB-107, (as well as similar observations for estrogenic
[51] and anti-estrogenic [87] activity for the parent PCB
118), a possible mechanism of neurodevelopmental toxi-
city is through hEST induction of estrogenic activity,
rather than binding directly to the estrogen receptor.
This could provide a coherent explanation for our
observations linking deficits in neurodevelopment to
Table 4 Final full multiple linear regression models of dioxin-like mono-ortho PCBs *
Maternal sera (n = 760)
MDI PDI
Variables Beta SE p value Beta SE p value
Dioxin-like mono-ortho PCBs (natural log transformed: ng/mg lipids) -1.60 0.45 < 0.001 -1.26 0.53 0.02
District: Michalovce vs. Svidnik -4.12 1.01 < 0.0001 -17.22 1.19 <0.0001
HOME score 1.23 0.10 < 0.0001 0.80 0.12 < 0.0001
Raven score 0.24 0.04 < 0.0001 0.25 0.04 < 0.0001
SEX: male vs. female 3.27 0.78 < 0.0001 3.40 0.92 0.0002
Cord sera (n = 258)
MDI PDI
Variables Beta SE p value Beta SE p value
Dioxin-like mono-ortho PCBs (natural log transformed: ng/mg lipids) -1.40 0.72 0.05 -1.99 0.87 0.02
District: Michalovce vs. Svidnik -4.15 1.77 0.02 -15.0 2.13 < 0.0001
HOME score 1.12 0.16 < 0.0001 0.64 0.19 <0.001
Raven score 0.20 0.06 0.001 0.38 0.08 < 0.0001
SEX: male vs. female 4.04 1.77 0.02 3.51 1.61 0.03
* This final model provides an estimate of the effect of dioxin-like mono-ortho PCBs in maternal and cord sera on the Bayley scales (MDI and PDI), adjusting for
district, HOME score, sex, maternal Raven’s score.
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Page 8 of 13PCB 118 and/or its metabolite, 4-OH-CB-107, but not
to the di-ortho congeners or their OH-metabolites.
Ah-receptor activity as shown for non-ortho substi-
tuted PCBs, is another plausible mechanism for the
associations we observed. On the one hand, dioxin-like
activity of mono-ortho PCBs occurs only at much higher
concentrations than that of coplanar PCBs or of 2,3,7,8-
TCDD; on the other, congeners #118 and #156 are pre-
sent, in virtually every human population studied, at
levels from 4 to 5 orders of magnitude greater than
2,3,7,8-TCDD itself (e.g., in U.S., European, and Japa-
nese studies [88-91]). Because of the exceedingly low
levels of the coplanar PCBs, furans, 2,3,7,8-TCDD and
other dioxins and the high cost to quantitate them, we
were unable to measure these compounds in cord and
maternal sera. However, in adult women aged 20-39
from the same population, i.e., the same two Slovak
towns, we have calculated TEQs using the WHO 2005
revised TEFs for mono-ortho PCBs (0.00003) for the
sum of PCB #118 and #156 (geometric mean TEQ, 1.36
pg/g lipid), and they are over four times higher than the
TEQs for 2,3,7,8-TCDD itself (0.32 pg/g lipid). In other
words, the lower toxicity was more than compensated
by the far higher abundance, supporting relevance of
dioxin-like activity from mono-ortho PCBs in this
population.
A cautionary note is in order, however: TEFs are cal-
culated based on intake and are not considered applic-
able to circulating levels in human tissues [17,92]. The
WHO 2005 report [17] calls for studies that would pro-
vide TEFs for tissue concentrations, but at present this
research has yet to be conducted. Whether the actual
TEQ in this study is higher or lower than we calculated
remains unclear, but the shorter half-life of PCB #118 in
comparison with that of 2,3,7,8-TCDD indicates rela-
tively greater intake would be required to maintain
blood levels, while the half-life of PCB #156 may be
similar to that of 2,3,7,8-TCDD [93]. The TEQs for
intake of the two mono-ortho PCBs together would
therefore likely be larger than what we have calculated
based on circulating concentrations. Also notable is a
recent effort to develop a Neurotoxic Equivalence
Scheme that would take into account multiple mechan-
isms [94]. Another concern about the calculation of
dioxin-like potencies in epidemiologic studies relates to
the difficulty in extrapolating from rat to human, given
that large differences in AhR-mediated gene expression
and EROD activity are observed even comparing rats
with mice [95].
Further concerns have focused on the presence of
impurities in test samples, specifically 2,3,7,8-substituted
polychlorinated dibenzo-dioxins (PCDDs), -furans
(PCDFs), or PCB 126 [17]. Our inability to measure
trace quantities of these compounds precludes drawing
inferences about the role of impurities, although other
data (personal communication with Dr. Kocan, 2009)
f r o mw o m e no fr o u g h l yt h es a m ea g er a n g ei nt h e s e
two towns demonstrate low correlations of the sum of
PCB #118+ #156 with 2,3,7,8-TCDD (0.016, p =0 . 9 4 )
and with coplanar PCBs (0.26, p = 0.23) and negative
correlations with PCDDs (-0.31, p =0 . 1 5 )a n dP C D F s
(-0.29, p = 0.17). Thus, the associations we observed for
neurocognitive developmental deficits with the sum of
the two most abundant mono-ortho PCBs are unlikely
to be a result of confounding from these other
compounds.
T h es u b s e tw i t hc o r dP C B sm e a s u r e dh a ds i m i l a r
sociodemographic characteristics to the larger group
with maternal PCBs, and sensitivity analyses did not
indicate selection bias. Since the mono-ortho-substituted
PCBs were present at relatively lower concentrations in
cord than maternal serum, whereas di-ortho-substituted
PCBs were at similar levels, these findings may indicate
that PCBs measured in the cord are more potent, and/
or a better marker of what reaches the target CNS tissue
in the fetus.
A large refusal rate (47 percent) for participation and
attrition (29 percent) of the follow-up represented a
study limitation. The eligibility of those who refused is
unknown, but given our exclusions based on residence
in the district, parity, and age, a substantial proportion
of the refusals may have been ineligible. Comparing
those lost to follow-up vs. those who stayed in the
study, lipid adjusted levels of 4 major PCBs (#138, #153,
#170, and #180) were not different (0.57, and 0.59 ng/
mg lipids, respectively) implying that the study losses
were not related with exposure levels. On the other
hand, there were some differences in regard to socio-
demographics (data not shown): those lost to follow-up
included more Romani (28.0 vs. 18.4 percent), more
Svidnik residents (37.0 vs. 26.7 percent), more partici-
pants with basic schooling only (28.0 vs. 18.6 percent),
and more women of low parity (49.2 vs. 38.3 percent)
compared to those who returned for the 16 month fol-
low-up visit. BSID scores for those lost to follow-up
were, by definition, not obtained in our study. Neverthe-
less, our final model included adjustments for HOME
and Raven’s scores, which relate to the infant’sn u r t u r -
ing environment at home and the mother’sI Qr e s p e c -
tively. If missingness was at random within any given
level of the adjustment variables, bias from non-random
loss of subjects would be less likely.
The means of MDI for the two psychologists were
similar (93.1 for Michalovce, n = 559; 95.7 for Svidnik,
n = 201), but lower than the mean scores of 100 in the
populations for which they are standardized. Because
the BSID has not been normed in the Slovak language
or culture, some cross-cultural or language differences
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Page 9 of 13might have played a role in the lower MDI scores in our
study [96]. Our research objective was to examine possi-
ble associations between prenatal PCBs and BSID scores
within this study cohort. Therefore, while comparisons
of BSID scores with other populations might not be
valid, the absolute scores are not the focus of our
investigation.
For reliability of the BSID scores, good agreement on
the MDI (ICC: 0.84) between raters was obtained. How-
ever, we were not able to evaluate reliability on the PDI
because the child frequently moved out of range of the
video camera during the test. Also, we observed a large
difference in mean scores of PDI, approximately 10
points, between two districts. This suggests the possibi-
lity of poor reliability across raters, and/or some other
unmeasured variables related to district that might have
resulted in the substantial difference in PDI. Therefore,
we also examined the effects of maternal dioxin-like-
PCBs in each district separately (results not shown). In
Michalovce, where the psychologist is more experienced,
we still observed significant associations, with similar
m a g n i t u d ea sf o rt h ee n t i r es a m p l e ,b e t w e e nm o n o -
ortho substituted PCBs and the Bayley scores; in Svid-
nik, the district with a less experienced psychologist, we
did not find any association with maternal mono-ortho
substituted PCBs. Overall, PCB exposure distributions
substantially overlapped for these two districts, however,
mean PCB levels were significantly higher in Michalovce
(which had a longer right tail) than in Svidnik (Figure 1).
Adjustment for district is required because it was a
design variable, but would not have constituted over-
adjustment for PCB concentrations.
As mercury and lead are well-known neurotoxins, we
considered the possibility of confounding. However, in a
sub-sample of the cohort, correlations between these
heavy metals and dioxin-like PCBs didn’t exist (correla-
tion coefficients were either negative or less than 0.03,
and none of them were significant). Although fish can
be a major source of methyl mercury, in other work
from our Slovak birth cohort, mothers’ fish consump-
tion was very low, contributing a negligible amount of
fat to the diet, and hence would not be expected to be
an important source of PCBs [97].
Multiple comparisons can be a problem in the study
because we tested 36 various combinations of PCBs and
outcomes. While some of our results could have been
due to chance, it is not possible statistically to determine
which ones are just random variations and which repre-
sent true underlying associations. P-values are based on
the assumption of the universal null hypothesis being
correct, whereas a priori knowledge motivated several of
t h eh y p o t h e s e sw ee x a m i n e d ,s p e c i f i c a l l yt h o s er e l a t e d
to different congener classes; in this situation, multiple
comparisons can be justifiable as part of a careful and
thorough evaluation of patterns of associations [98].
Notably, our significant results were not sporadic, as
would be expected if they were chance findings, but
rather showed a pattern whereby dioxin-like congeners
Figure 1 Maternal dioxin-like mono-ortho-substituted PCB concentrations (ng/mg lipids) by district.
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Page 10 of 13showed the strongest associations in all analyses: cord or
maternal serum, MDI or PDI. Furthermore, the pattern
is upheld by our analysis of hydroxy-metabolites of
PCBs: of the six that we evaluated, the only one asso-
ciated with neurobehavioral deficits was 4-OH-PCB107,
the metabolite for PCB #118 and another mono-ortho
congener [74].
Several strengths are worth emphasizing: the large
sample size; direct exposure assessments of prenatal
PCBs rather than using a surrogate such as breast-milk
or fish consumption during pregnancy; good quality
control of laboratory measurements. Unfortunately, not
many previous epidemiological studies have examined
functionally-defined subsets of PCB congeners, and
fewer still have done so in relation to neurodevelop-
ment. Also, we were able to measure only a limited ros-
ter and some were present at very low levels relative to
our limits for quantitation, which prevented a more
definitive assessment of associations with regard to neu-
rodevelopment in children.
A change in a few points on the Bayley scales may
seem clinically unimportant for an individual child.
However, beginning with studies from the population
level, it can be predicted that a slight shift in the mean
performance in the adverse direction can result in a
substantial increase in the number of children who are
in the subnormal range in the clinical setting [99].
Conclusion
Based on the results herein, the high levels of mono-
ortho PCBs, and the literature on dioxin-like activity in
relation to neurodevelopment, we conclude that the
associations of prenatal dioxin-like mono-ortho PCBs, in
either maternal or cord serum, with decreased perfor-
mance in both the cognitive and motor domains based
on BSID scores could plausibly be causal. However, a
suggestive association of di-ortho-substituted PCBs with
decreased motor development was found in cord but
not maternal serum, and we did not find statistically sig-
nificant associations with anti-estrogenic PCBs.
Abbreviations
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